Dabigatran etexilate for preventing venous thromboembolism after hip or knee replacement surgery

  • Technology appraisal guidance
  • TA157
  • Published: 
Download guidance (PDF)

1 Recommendations

1.1

Dabigatran etexilate is recommended, within its marketing authorisation, as an option for preventing venous thromboembolism in adults after elective hip or knee replacement surgery.